In late 2017, a federal watchdog unit assigned a working group to keep an eye on cryptocurrencies such as Bitcoin, and to sound an alert if those alternate currencies showed signs of becoming a risk to the stability of the US... Read more »
Trefoil Therapeutics, which is developing treatments for diseases that affect the cornea, the outermost layer of the eye, has raised $28 million to move its lead drug candidate into human testing.
The company is developing an engineered form of fibroblast growth... Read more »
Another company headed by former Illumina executives has launched, fueled with a $17 million Series A round from investors including a local venture capital firm.
The new firm, Cradle Genomics, is seeking to commercialize improved non-invasive prenatal tests, which analyze blood... Read more »
Eight years after San Diego biotech Prometheus Laboratories was acquired by Nestlé Health Science, the diagnostic business has been sold again, this time to a little-known biotech called Precision IBD that plans to lay off approximately a quarter of Prometheus’s... Read more »
Broadcom is once, twice, three times a multi-billion-dollar dealmaker (well, basically) in the past year if it follows through on its reported talks to acquire Mountain View, CA-based cybersecurity giant Symantec.
Providence St. Joseph Health, a Renton, WA-based organization that operates 51 hospitals and 829 clinics across five US states, announced its latest strategic, IT-focused acquisition last week. The company Providence has agreed to purchase—financial terms aren’t being disclosed—is Bluetree Network... Read more »
Brain Corp., a robotics startup whose technology powers automated floor cleaning machines in retail stores, malls, warehouses, and airports, announced Monday it is opening its first European office in Amsterdam, the largest city in the Netherlands.
The Amsterdam office will serve... Read more »
Degreed, which helps businesses upgrade the skills of their staffers through an online gateway to learning resources, announced Thursday it has raised $75 million to grow the service and expand internationally.
San Francisco-based Degreed is among the educational technology companies... Read more »
Mirati Therapeutics plans to raise more than $200 million this week in a public offering, funding that it plans to use to advance its lead cancer drug candidate, sitravatinib, into late-stage testing, and to continue developing its other targeted oncology programs.... Read more »
President and CEO, Molecular Assemblies; strategic advisor, Microdermis; co-founder, board member, Genoa Pharmaceuticals
Founder and CEO, Noble Environmental Technologies
Founder and CEO, Isis Pharmaceuticals
CEO, Cognionics Inc.
Co-Founder and CEO, Arena Pharmaceuticals
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Founder, Inception Sciences
Founder and Managing Partner, City Hill Ventures
Prof., Molecular Biology and Chemistry, Scripps Research Institute
Co-Founder and Executive Chairman, CleanTECH San Diego
Professor, Gene Expression Laboratory, Salk Institute